CAS 141732-76-5
:Acétate d'exénatide
- His-Gly-Gly-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH{2}
- ExenatideAcetate
- Exenatide
- EXENATIDE ACETATE
- ENFUVIRTIDE ACETATE
- EXENATIDE ACETATE(EXENDIN-4)
Exenatide Acetate
CAS :Formule :C186H286N50O62SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :4246.6238Exenatide Acetate
CAS :Formule :C186H286N50O62SDegré de pureté :95%~99%Couleur et forme :White to Off-white PowderMasse moléculaire :4262.67Exenatide
CAS :Exenatide (Extendin-4) is a glucagon-like protein-1 (GLP-1) receptor agonist.Formule :C186H286N50O62SDegré de pureté :99.42%Couleur et forme :SolidMasse moléculaire :4247Exenatide-d5 Acetate
CAS :Produit contrôléApplications Exenatide-d5 Acetate is labelled Exenatide Acetate (E957300) which causes an increase in acinar cAMP without stimulating amylase release. Exenatide has found use as a medication of diabetes II.
References Pugazhenthi, U. et al.: Diabetol., 53, 2357 (2010); Li, C. et al.: Bioche,. Biophys. Res. Comm., 400, 563 (2010); Lupi, R. et al.: Diab. Obes. Metab., 10, 515 (2008); Kim, T.H. et al.: Bioconj. Chem., 22, 625 (2011);Formule :C186H281D5N50O62SCouleur et forme :NeatMasse moléculaire :4251.71Exenatide Acetate
CAS :Produit contrôléApplications A 39-amino acid peptide originally isolated from the salivary glands of the Gila monster (Heloderma suspectum), differs from exendin-3 only in two positions close to the N-terminus. Application of exenatide causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatide acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatide augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatide has found use as a medication of diabetes II.
References Pugazhenthi, U. et al.: Diabetol., 53, 2357 (2010); Li, C. et al.: Bioche,. Biophys. Res. Comm., 400, 563 (2010); Lupi, R. et al.: Diab. Obes. Metab., 10, 515 (2008); Kim, T.H. et al.: Bioconj. Chem., 22, 625 (2011);Formule :C186H286N50O62SCouleur et forme :NeatMasse moléculaire :4246.62Exenatide acetate
CAS :Agonist of glucagon-like peptide GLP1 which is used for treatment of type 2 diabetes mellitus. Exenatide is more resistant to degradation by dipeptidyl peptidase IV than GLP1 and possesses GLP1-like glucoregulatory activities such as stimulation of insulin production by pancreatic β cells and lowering of serum glucagon levels during hyperglycaemia. In a mouse model for type 2 diabetes, exenatide was shown to reverse neuropathy and to possess anxiolytic and anti-depressant-like effects.
Formule :C184H282N50O60S·C2H4O2Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :4246.63Exenatide Acetate (1 to 12)
CAS :Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool
Formule :C54H83N15O21Masse moléculaire :1,278.4 g/mol








